{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:23Z","timestamp":1790713223869,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.clbc.2020.05.006","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T09:14:46Z","timestamp":1589361286000},"page":"480-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-6284","authenticated-orcid":false,"given":"Ciro","family":"Franzese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Comito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Vigan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Pedicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1142-2439","authenticated-orcid":false,"given":"Davide","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0296-7648","authenticated-orcid":false,"given":"Matteo","family":"Donadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Poretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3109-1449","authenticated-orcid":false,"given":"Luigi","family":"Solbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Torzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2020.05.006_bib1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Soerjomataram","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2020.05.006_bib2","series-title":"SEER Cancer Statistics Review","year":"1975"},{"key":"10.1016\/j.clbc.2020.05.006_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.05.006_bib4","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2020.05.006_bib5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1186\/s12885-019-6311-z","article-title":"The clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"issue":"15 Suppl","key":"10.1016\/j.clbc.2020.05.006_bib6","doi-asserted-by":"crossref","first-page":"e11512","DOI":"10.1200\/jco.2012.30.15_suppl.e11512","article-title":"Incidence and implications of oligometastatic breast cancer","volume":"30","author":"Jain","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.05.006_bib7","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ejca.2011.06.024","article-title":"Hepatic resection for metastatic breast cancer: a systematic review","volume":"47","author":"Chua","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2020.05.006_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ejso.2011.04.013","article-title":"Liver resection and local ablation of breast cancer liver metastases - a systematic review","volume":"37","author":"Bergenfeldt","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2020.05.006_bib9","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1245\/s10434-015-5009-y","article-title":"Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An observational cohort","volume":"23","author":"Vigan\u00f2","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2020.05.006_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.hpb.2017.05.006","article-title":"Twelve-year experience of \u201cradical but conservative\u201d liver surgery for colorectal metastases: impact on surgical practice and oncologic efficacy","volume":"19","author":"Torzilli","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.clbc.2020.05.006_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1359-6349(09)70018-7","article-title":"New response evaluation criteria in solid tumors: RECIST guideline version 1.1","volume":"7","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer Suppl"},{"issue":"Suppl 1","key":"10.1016\/j.clbc.2020.05.006_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00259-017-3687-3","article-title":"Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments","volume":"44","author":"Pinker","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clbc.2020.05.006_bib13","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.suronc.2009.06.005","article-title":"Surgical resection of liver metastases from breast cancer","volume":"19","author":"Lermite","year":"2010","journal-title":"Surg Oncol"},{"key":"10.1016\/j.clbc.2020.05.006_bib14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11547-014-0489-6","article-title":"Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer","volume":"120","author":"K\u00fcmler","year":"2015","journal-title":"Radiol Medica"},{"key":"10.1016\/j.clbc.2020.05.006_bib15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2214\/ajr.172.4.10587129","article-title":"Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma","volume":"172","author":"Sheafor","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clbc.2020.05.006_bib16","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.ejrad.2013.06.013","article-title":"Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation","volume":"82","author":"B\u00f6ttcher","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clbc.2020.05.006_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2967\/jnumed.107.047787","article-title":"Recommendations on the use of 18F-FDG PET in oncology","volume":"49","author":"Fletcher","year":"2008","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.clbc.2020.05.006_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jvir.2017.09.027","article-title":"Stereotactic radiofrequency ablation for breast cancer liver metastases","volume":"29","author":"Bale","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.clbc.2020.05.006_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2012.12.021","article-title":"Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial","volume":"86","author":"Scorsetti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2020.05.006_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.clon.2010.05.021","article-title":"Heterogeneity of metabolic response to\u00a0systemic therapy in metastatic breast cancer patients","volume":"22","author":"Huyge","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clbc.2020.05.006_bib21","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/cancers11091341","article-title":"Local treatment of breast cancer liver metastasis","volume":"11","author":"Bale","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2020.05.006_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2018.02.024","article-title":"Surgical resection versus systemic therapy for breast cancer liver metastases: results of a European case matched comparison","volume":"95","author":"Ruiz","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2020.05.006_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4251\/wjgo.v12.i2.228","article-title":"Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: a systematic review","volume":"12","author":"Feretis","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.clbc.2020.05.006_bib24","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.21873\/anticanres.13442","article-title":"Comparison of response and outcomes of drug-eluting bead chemoembolization (DEB-TACE) versus radioembolization (TARE) for patients with colorectal cancer liver metastases","volume":"39","author":"Mokkarala","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clbc.2020.05.006_bib25","first-page":"djx015","volume":"109","author":"Ruers","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2020.05.006_bib26","doi-asserted-by":"crossref","first-page":"e0190098","DOI":"10.1371\/journal.pone.0190098","article-title":"Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: from clinical aspects to dosimetry","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920301087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920301087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:51Z","timestamp":1761513591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820920301087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1526820920301087"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2020.05.006","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2020.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}